103 related articles for article (PubMed ID: 22403273)
1. PTH--a particularly tricky hormone: why measure it at all in kidney patients?
Garrett G; Sardiwal S; Lamb EJ; Goldsmith DJ
Clin J Am Soc Nephrol; 2013 Feb; 8(2):299-312. PubMed ID: 22403273
[TBL] [Abstract][Full Text] [Related]
2. Parathyroid hormone measurement in CKD.
Souberbielle JC; Roth H; Fouque DP
Kidney Int; 2010 Jan; 77(2):93-100. PubMed ID: 19812537
[TBL] [Abstract][Full Text] [Related]
3. Rebuttal: PTH--a particularly tricky hormone: why measure it at all in kidney patients?
Sprague SM; Moe SM
Clin J Am Soc Nephrol; 2013 Feb; 8(2):321. PubMed ID: 23160258
[No Abstract] [Full Text] [Related]
4. The case for routine parathyroid hormone monitoring.
Sprague SM; Moe SM
Clin J Am Soc Nephrol; 2013 Feb; 8(2):313-8. PubMed ID: 23037984
[TBL] [Abstract][Full Text] [Related]
5. Current parathyroid hormone immunoassays do not adequately meet the needs of patients with chronic kidney disease.
Almond A; Ellis AR; Walker SW;
Ann Clin Biochem; 2012 Jan; 49(Pt 1):63-7. PubMed ID: 22096021
[TBL] [Abstract][Full Text] [Related]
6. Serum level of fibroblast growth factor 23 in maintenance renal transplant patients.
Sánchez Fructuoso AI; Maestro ML; Pérez-Flores I; Valero R; Rafael S; Veganzones S; Calvo N; De la Orden V; De la Flor JC; Valga F; Vidaurreta M; Fernández-Pérez C; Barrientos A
Nephrol Dial Transplant; 2012 Nov; 27(11):4227-35. PubMed ID: 23144073
[TBL] [Abstract][Full Text] [Related]
7. The relationship between apelin and parathyroid hormone in hemodialysis patients.
Mafra D; Lobo JC; Farage NE; Stockler-Pinto MB; Leal VO; Calixto A; Geloneze B
Ren Fail; 2012; 34(8):970-3. PubMed ID: 22780711
[TBL] [Abstract][Full Text] [Related]
8. Comments on plasma parathyroid hormone levels and their relationship to bone histopathology among patients undergoing dialysis.
Goodman WG
Semin Dial; 2007; 20(1):1-4. PubMed ID: 17244110
[TBL] [Abstract][Full Text] [Related]
9. Critical issues of PTH assays in CKD.
Komaba H; Goto S; Fukagawa M
Bone; 2009 Apr; 44(4):666-70. PubMed ID: 19159701
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of variability in determining intact parathyroid hormone (iPTH) according to the method used to process the sample].
Morales García AI; Górriz Teruel JL; Plancha Mansanet MC; Escudero Quesada V; Pallardó Mateu LM
Nefrologia; 2009; 29(4):331-5. PubMed ID: 19668305
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone metabolism and signaling in health and chronic kidney disease.
Evenepoel P; Bover J; Ureña Torres P
Kidney Int; 2016 Dec; 90(6):1184-1190. PubMed ID: 27653840
[TBL] [Abstract][Full Text] [Related]
12. Parathyroid hormone changes during phosphorus load in patients with chronic renal insufficiency with low serum parathyroid hormone or adynamic bone disease.
Cuppari L; Carvalho AB; Lobão RR; Martini LA; Cendoroglo M; Ventura RT; Draibe SA
Clin Nephrol; 2001 Jul; 56(1):35-43. PubMed ID: 11499657
[TBL] [Abstract][Full Text] [Related]
13. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
14. Parathyroid hormone measurement in chronic kidney disease--an evolving issue for the nephrologist and the clinical laboratorist: minireview.
Correale M
Immunopharmacol Immunotoxicol; 2012 Aug; 34(4):541-7. PubMed ID: 22208997
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of PTH/PTHrP receptor in the kidney of patients with renal impairment.
Chen J; Zhang J; Lin S
Chin Med J (Engl); 1998 Jan; 111(1):24-7. PubMed ID: 10322647
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy of serum parathyroid hormone levels in kidney transplant recipients with moderate-to-advanced CKD.
Kovesdy CP; Molnar MZ; Czira ME; Rudas A; Ujszaszi A; Sarvary E; Ambrus C; Szathmari M; Remport A; Mucsi I
Nephron Clin Pract; 2011; 118(2):c78-85. PubMed ID: 21150215
[TBL] [Abstract][Full Text] [Related]
17. Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease.
Zisman AL; Hristova M; Ho LT; Sprague SM
Am J Nephrol; 2007; 27(1):36-43. PubMed ID: 17215573
[TBL] [Abstract][Full Text] [Related]
18. Reelevation of parathyroid hormone level after parathyroidectomy in patients with primary hyperparathyroidism: importance of decreased renal parathyroid hormone sensitivity.
Yamashita H; Noguchi S; Moriyama T; Takamatsu Y; Sadanaga K; Uchino S; Watanabe S; Ogawa T
Surgery; 2005 Apr; 137(4):419-25. PubMed ID: 15800489
[TBL] [Abstract][Full Text] [Related]
19. Differences between serum and plasma for intact parathyroid hormone measurement in patients with chronic renal failure in routine clinical practice.
Twomey PJ; Whitlock T; Pledger DR
J Clin Pathol; 2005 Sep; 58(9):1000-1. PubMed ID: 16126890
[TBL] [Abstract][Full Text] [Related]
20. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).
Bhuriya R; Li S; Chen SC; McCullough PA; Bakris GL
Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S3-10. PubMed ID: 19285609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
